Elicityl Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • 2ndary - Private

Elicityl General Information

Description

Operator of a biotechnology agency intended to focus on complex life science engineering and production. The company's agency specializes in the supply of oligosaccharides and polysaccharides for biological applications targeting plant health, pharmacy, nutraceuticals and cosmetics, enabling clients to innovative industrial methods of production.

Contact Information

Website
www.elicityl-oligotech.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 746 avenue Ambroise Croizat
  • 38920 Crolles
  • France
+33 04
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 746 avenue Ambroise Croizat
  • 38920 Crolles
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elicityl Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Oct-2021 Completed Generating Revenue
3. Later Stage VC 27-Sep-2015 Completed Generating Revenue
2. Later Stage VC 25-Sep-2007 $858K $1.26M Completed Generating Revenue
1. Early Stage VC $405K $405K Completed Startup
To view Elicityl’s complete valuation and funding history, request access »

Elicityl Patents

  • 35

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Elicityl Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4304656-A1 Conjugates including multiple saccharidic chains on a linear protein and uses in mammals feed Pending 08-Mar-2021
US-20240050582-A1 Conjugates including multiple saccharidic chains on a linear protein and uses in mammals feed Pending 08-Mar-2021
WO-2022189361-A1 Conjugates including multiple saccharidic chains on a linear protein and uses in mammals feed Inactive 08-Mar-2021
CA-3158208-A1 Use of alginates oligomers to improve plant protection against pathogens Pending 19-Dec-2019
EP-4075978-A1 Use of alginates oligomers to improve plant protection against pathogens Inactive 19-Dec-2019 A01N65/03
To view Elicityl’s complete patent history, request access »

Elicityl Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Elicityl FAQs

  • When was Elicityl founded?

    Elicityl was founded in 2002.

  • Where is Elicityl headquartered?

    Elicityl is headquartered in Crolles, France.

  • What is the size of Elicityl?

    Elicityl has 11 total employees.

  • What industry is Elicityl in?

    Elicityl’s primary industry is Pharmaceuticals.

  • Is Elicityl a private or public company?

    Elicityl is a Private company.

  • What is Elicityl’s current revenue?

    The current revenue for Elicityl is .

  • How much funding has Elicityl raised over time?

    Elicityl has raised $2.28M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process